THERAJECT

Theraject is a biotechnology company specializing in the development of dissolvable microneedle technology for the transdermal delivery of drugs and vaccines. The company's proprietary platform, often referred to as Vax-Patch, utilizes micro-scale needles that dissolve upon skin penetration, releasing the encapsulated therapeutic agent directly into the intradermal layer. This technology aims to provide a painless, needle-free alternative to traditional injections, improving patient compliance and potentially enhancing immune responses for vaccines. Theraject focuses on a wide range of applications, including influenza vaccines, insulin delivery for diabetes, and localized pain management. The company operates with a focus on both internal development and strategic partnerships with pharmaceutical firms to adapt its delivery system for various biologics and small molecules.